Advanced Medical Optics (AMO) has received approval from the U.S. Food and Drug Administration (FDA) to market its CustomVue Monovision LASIK product, which is said to be the first LASIK device capable of treating one eye for myopia and the other eye for presbyopia.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.